Medical Crossfire®: Clinical Decision Making Under New Paradigms for HR+/HER2-Breast Cancer
Presented by Physicians’ Education Resource, LLC
This activity is supported by educational grants from Gilead, Menarini-Stemline, Sanofi Genzyme, and Veru, Inc.